Literature DB >> 28753379

Gene Expression Signatures in Tuberculosis Have Greater Overlap with Autoimmune Diseases Than with Infectious Diseases.

Kalum Clayton1, Marta E Polak1, Christopher H Woelk1, Paul Elkington1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28753379      PMCID： PMC5620671          DOI： 10.1164/rccm.201706-1248LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

Review 1.  Systemic lupus erythematosus: all roads lead to type I interferons.

Authors:  Virginia Pascual; Lorant Farkas; Jacques Banchereau
Journal:  Curr Opin Immunol       Date:  2006-10-02       Impact factor: 7.486

Review 2.  Update in Tuberculosis/Pulmonary Infections 2015.

Authors:  Serena P Koenig; Jennifer Furin
Journal:  Am J Respir Crit Care Med       Date:  2016-07-15       Impact factor: 21.405

3.  Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.

Authors:  Catherine W M Ong; Paul T Elkington; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

Review 4.  Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers.

Authors:  Robert S Wallis; Markus Maeurer; Peter Mwaba; Jeremiah Chakaya; Roxana Rustomjee; Giovanni Battista Migliori; Ben Marais; Marco Schito; Gavin Churchyard; Soumya Swaminathan; Michael Hoelscher; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2016-04       Impact factor: 25.071

5.  Towards host-directed therapies for tuberculosis.

Authors:  Alimuddin Zumla; Markus Maeurer; Jeremiah Chakaya; Michael Hoelscher; Francine Ntoumi; Roxana Rustomjee; Cristina Vilaplana; Dorothy Yeboah-Manu; Voahangy Rasolof; Paula Munderi; Nalini Singh; Eleni Aklillu; Nesri Padayatchi; Eusebio Macete; Nathan Kapata; Modest Mulenga; Gibson Kibiki; Sayoki Mfinanga; Thomas Nyirenda; Leonard Maboko; Alberto Garcia-Basteiro; Niaina Rakotosamimanana; Matthew Bates; Peter Mwaba; Klaus Reither; Sebastien Gagneux; Sarah Edwards; Elirehema Mfinanga; Salim Abdulla; Pere-Joan Cardona; James B W Russell; Vanya Gant; Mahdad Noursadeghi; Paul Elkington; Maryline Bonnet; Clara Menendez; Tandakha N Dieye; Bassirou Diarra; Almoustapha Maiga; Abraham Aseffa; Shreemanta Parida; Christian Wejse; Eskild Petersen; Pontiano Kaleebu; Matt Oliver; Gill Craig; Tumena Corrah; Leopold Tientcheu; Martin Antonio; Martin Rao; Timothy D McHugh; Aziz Sheikh; Giuseppe Ippolito; Gita Ramjee; Stefan H E Kaufmann; Gavin Churchyard; Andrie Steyn; Martin Grobusch; Ian Sanne; Neil Martinson; Rajhmun Madansein; Robert J Wilkinson; Bongani Mayosi; Marco Schito; Robert S Wallis
Journal:  Nat Rev Drug Discov       Date:  2015-07-17       Impact factor: 84.694

6.  Tuberculosis: An Infection-Initiated Autoimmune Disease?

Authors:  Paul Elkington; Marc Tebruegge; Salah Mansour
Journal:  Trends Immunol       Date:  2016-10-21       Impact factor: 16.687

7.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

Review 8.  The human immune response to tuberculosis and its treatment: a view from the blood.

Authors:  Jacqueline M Cliff; Stefan H E Kaufmann; Helen McShane; Paul van Helden; Anne O'Garra
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

9.  Association between a history of mycobacterial infection and the risk of newly diagnosed Sjögren's syndrome: A nationwide, population-based case-control study.

Authors:  Wen-Cheng Chao; Ching-Heng Lin; Tsai-Ling Liao; Yi-Ming Chen; Der-Yuan Chen; Hsin-Hua Chen
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

Review 10.  Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.

Authors:  Bas C Mourik; Erik Lubberts; Jurriaan E M de Steenwinkel; Tom H M Ottenhoff; Pieter J M Leenen
Journal:  Front Immunol       Date:  2017-04-05       Impact factor: 7.561
  10 in total
  9 in total

1.  Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition.

Authors:  Paul T Elkington; Adrian C Bateman; Gareth J Thomas; Christian H Ottensmeier
Journal:  Am J Respir Crit Care Med       Date:  2018-12-01       Impact factor: 21.405

2.  TREM-1 Response Signatures Common to Expression Profiles of Both Asthma Affection and Asthma Control.

Authors:  Damien C Croteau-Chonka; Benjamin A Raby
Journal:  Am J Respir Crit Care Med       Date:  2018-08-01       Impact factor: 21.405

3.  Reconsidering the Optimal Immune Response to Mycobacterium tuberculosis.

Authors:  Liku B Tezera; Salah Mansour; Paul Elkington
Journal:  Am J Respir Crit Care Med       Date:  2020-02-15       Impact factor: 21.405

Review 4.  The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy.

Authors:  Cari Stek; Brian Allwood; Naomi F Walker; Robert J Wilkinson; Lutgarde Lynen; Graeme Meintjes
Journal:  Front Microbiol       Date:  2018-10-30       Impact factor: 5.640

Review 5.  Understanding the tuberculosis granuloma: the matrix revolutions.

Authors:  Paul Elkington; Marta E Polak; Michaela T Reichmann; Alasdair Leslie
Journal:  Trends Mol Med       Date:  2021-12-15       Impact factor: 11.951

Review 6.  The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis.

Authors:  Akul Singhania; Robert J Wilkinson; Marc Rodrigue; Pranabashis Haldar; Anne O'Garra
Journal:  Nat Immunol       Date:  2018-10-17       Impact factor: 25.606

7.  Integrated transcriptomic analysis of human tuberculosis granulomas and a biomimetic model identifies therapeutic targets.

Authors:  Michaela T Reichmann; Liku B Tezera; Andres F Vallejo; Milica Vukmirovic; Rui Xiao; James Reynolds; Sanjay Jogai; Susan Wilson; Ben Marshall; Mark G Jones; Alasdair Leslie; Jeanine M D'Armiento; Naftali Kaminski; Marta E Polak; Paul Elkington
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

8.  Association of the Risk of Primary Sjögren's Syndrome With Fibrocystic Breast Disease: A Nationwide, Population-Based Study.

Authors:  Hsin-Hua Chen; Hsian-Min Chen; Ching-Heng Lin; Kuo-Tung Tang; Der-Yuan Chen; James Cheng-Chung Wei; Wen-Cheng Chao
Journal:  Front Med (Lausanne)       Date:  2021-07-01

9.  Malaria systems immunology: Plasmodium vivax induces tolerance during primary infection through dysregulation of neutrophils and dendritic cells.

Authors:  Andres F Vallejo; Robert C Read; Myriam Arevalo-Herrera; Sócrates Herrera; Tim Elliott; Marta E Polak
Journal:  J Infect       Date:  2018-09-22       Impact factor: 6.072
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.